Table 1.
Summary of the study characteristics including all values for PAD patients (ABPI is taken at rest in the worst affected limb an data are presented as mean ±SD)
| Author, year | Sample size (n) | Age (years) | Males (%) | ABPI | Intervention | QoL used | |
|---|---|---|---|---|---|---|---|
| 1 | Shuriquie et al. [37] | 96 | 59 ± 15.6 | 65 (67.7) |
Not reported | Bypass surgery | AUSVIQOL – Arabic |
| 2 | Haitjema et al. [16] | 865 | 68 | 623 (72.0) |
0.59 ± 0.21 | Endarterectomy | SF36 |
| 3 | Prévost et al. [36] | 46 | 60.3 ± 8 | 40 (87.0) |
0.7 ± 0.1 | Home exercise programme | SF36 – French |
| 4 | Maksimovic et al. [28] | 102 | 68.9 ± 8 | 33 (32.4) |
Not reported | None | SF36 – Serbian |
| 5 | Inglis et al. [21] | 173 | 60.5 ± 15.4 | 70 (40.5) |
Not reported | None | SF12 |
| 6 | Guidon and McGee 2013 [14] | 44 | 67 ± 8 | 33 (75.0) |
0.77 ± 0.21 | Supervised exercise | WIQ SF36 ICQ |
| 7 | Fritschi et al. [12] | 105 | 68.9 ± 8.35 | 64 (61.0) |
Not reported | None | SF36 WIQ |
| 8 | Frans et al. [11] | 40 | 67 | 25 (62.5) |
0.67 ± 0.21 | None | SF36 VascuQoL ALDS |
| 9 | Lee et al. [26] | 63 | 55 ± 12 | 15 (23.8) |
Not reported | None | PAQ |
| 10 | Fakhry et al. [10] | 217 | 67.5 ± 9.5 | 135 (62.2) |
0.62 ± 0.19 | Home exercise programme vs. supervised exercise programme | SF36 EuroQoL VascuQoL |
| 11 | Malagoni et al. [29] | 250 | 70.5 ± 9.2 | 191 (76.4) |
Not reported | Home exercise programme | SF36 |
| 12 | Yan et al. [42] | 134 | 71 ± 9 | 94 (70.1) |
0.6 ± 0.2 | None | WIQ |
| 13 | Hedeager Momsen et al. [19] | 88 | 67.4 ± 6.9 | 56 (63.6) |
0.53 | Revascularisation | SF36 WIQ |
| 14 | Leicht et al. [27] | 28 | 69 ± 7.6 | 22 (78.6) |
0.7 ± 0.1 | None | ICQ SF36 |
| 15 | Tsai et al. [39] | 53 | 76.2 ± 3.7 | 44 (83.0) |
0.7 ± 0.1 | Supervised exercise programme | SF36 – Chinese |
| 16 | Breek et al. [6] | 151 | 63 | 100 (66.2) |
Not reported | None | WHOQoL-100 |
| 17 | Bosch and Hunink [4] | 254 | 58 | 183 (72.0) |
Not reported | None | RAND-36 HUI3 EQ5D |
| 18 | Hicken et al. [20] | 96 | 68 | 64 (66.7) |
>0.9 | None | EQ5D |
| 19 | Mangiafico et al. [30] | 42 | 64 ± 8 | 37 (88.1) |
0.55 ± 0.22 | Drug intervention (prostaglandin) | WIQ RAND-36 |
| 20 | Bartman et al. [2] | 44 | 70.5 ± 6 | 43 (97.7) |
<0.9 | None | SF36 HUI3 Rating scale |
| 21 | Cook and Galland [9] | 24 | 66 | 12 (50.0) |
Not reported | Revascularisation | EuroQoL Walking distance score Visual analog scale |
| 22 | Je et al. [22] | 149 | 70.3 ± 9.7 | 125 (83.9) |
0.75 ± 0.24 | Revascularisation | PAQ |
| 23 | Oka and Sanders [34] | 74 | 72 ± 7 | 56 (75.7) |
0.67 ± 0.14 | None | SF36 |
| 24 | Gardner et al. [13] | 201 | 67 ± 9 | 159 (79.1) |
0.7 ± 0.22 | None | SF36 WIQ |
| 25 | Kalbaugh et al. [23] | 54 | 64.5 ± 11.2 | Not reported | Not reported | Revascularisation | SF36 |
| 26 | Nicolai et al. [33] | 91 | 66.2 ± 9.6 | 56 (61.5) |
0.72 ± 0.17 | Supervised exercise programme | WIQ RAND-36 EuroQoL |
| 27 | Keeling et al. [24] | 40 | 63 | 25 (62.5) |
Not reported | Revascularisation | SF36 |
| 28 | Virkkunen et al. [40] | 27 | 69.3 ± 10.7 | Not reported | 0.63 | Revascularisation | NHP |
| 29 | Aquarius et al. [1] | 188 | 64.7 ± 9.9 | 119 (63.3) |
0.61 | None | RAND-36 WHOQoL-100 |
| 30 | Breek et al. [5] | 200 | 63 | 135 (67.5) |
0.62 | None | RAND-36 WHOQoL-100 |
| 31 | Spertus et al. [38] | 44 | 68 ± 11 | 24 (54.5) |
Not reported | None | PAQ WIQ SF36 |
ABPI ankle-brachial pressure index